Metabolic cross‐talk between astrocytes and neurons: implications for Alzheimer’s disease
Alzheimer's & Dementia · 2023-12 · 19 (S13)
DOI: 10.1002/alz.076100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 25.12.2023. Verfasst von Simona Magi und 6 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Themen: Demenz
Abstract (Originalsprache)
Background
Converging evidence indicates that declining brain energetics contributes to the initiation and progression of neurodegenerative disorders, including Alzheimer’s disease (AD). Upstream events often characterizing AD include hypometabolism of glucose and oxygen in the brain, which may cause mitochondrial dysfunction, energetic failure, and oxidative stress (Moreira et al., 2010). Astrocytes, which have a main role in supporting neuronal function and metabolism, might contribute to the development of neurodegenerative diseases. By modulating the release of gliotransmitters (e.g. glutamate), they provide a fine control of neuronal metabolism and cell‐to‐cell communication, both of them involved in AD (Monterey et al., 2021). Impaired astrocytes metabolism may incite an inflammatory response that, in turn, negatively impacts neuronal viability.
Method
Primary rat cortical astrocytes were isolated from the cortex of Wistar rat pups. A metabolic stress was induced by using glyceraldehyde (GA) (Magi et al., 2021). We evaluated cell viability, the release of tumor necrosis factor alpha (TNFα) and the involvement of the nuclear factor‐kappa B (NF‐kB) pathway. In order to check the glutamate turnover, we analyzed the expression of GLAST and GLT1 and we evaluated the ATP content after glutamate exposure under physiological conditions. We also explored whether damaged astrocytes could elicit neuronal death in a co‐culture setting.
Result
Exposure to increasing concentrations of GA caused a concentration‐dependent cell injury in rat cortical astrocytes. GA (1mM) started to induce a significant cell damage after 24 h. After 48 h, GA exposure activated the NF‐kB pathway and the release of TNFα. GA treatment significantly increased GLAST and GLT1 levels after 48h. When injured astrocytes were co‐cultured with cortical neurons, neurons viability significantly decreased. Under physiological condition, glutamate significantly improved intracellular ATP levels after 4 and 8 hours of treatment, paving the way to the evaluation of its action in metabolic‐impaired setting, as induced by GA treatment.
Conclusion
Our results suggest that metabolically impaired astrocytes may damage neighboring neurons, suggesting astrocytes involvement in the pathophysiological development and progression of AD. Therefore, astrocytes can be considered a key therapeutic and neuroprotective target for future studies.
Zitieren
APA
Magi, S., Preziuso, A., Piccirillo, S., Cerqueni, G., Serfilippi, T., Lariccia, V., & Amoroso, S. (2023). Metabolic cross‐talk between astrocytes and neurons: implications for Alzheimer’s disease. Alzheimer's & Dementia, 19(S13). https://doi.org/10.1002/alz.076100
Vancouver
Magi S, Preziuso A, Piccirillo S, Cerqueni G, Serfilippi T, Lariccia V, et al. Metabolic cross‐talk between astrocytes and neurons: implications for Alzheimer’s disease. Alzheimer's & Dementia. 2023;19(S13). doi:10.1002/alz.076100
BibTeX
@article{Magi2023,
author = {Magi, Simona and Preziuso, Alessandra and Piccirillo, Silvia and Cerqueni, Giorgia and Serfilippi, Tiziano and Lariccia, Vincenzo and Amoroso, Salvatore},
title = {Metabolic cross‐talk between astrocytes and neurons: implications for Alzheimer’s disease},
journal = {Alzheimer's & Dementia},
year = {2023},
volume = {19},
number = {S13},
doi = {10.1002/alz.076100}
}
EUVIMED